Overview
Le-le Zhang practices practicing medicine in Guangzhou, China.
Their clinical expertise encompasses Dendritic Cell Tumor, Cerebral Hypoxia, Mononucleosis, and Nasopharyngeal Carcinoma.
They are actively involved in clinical research, co-authoring 8 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Le-le Zhang
Is Le-le Zhang a top-rated expert for Dendritic Cell Tumor?
MediFind is an objective health platform that identifies experts based on real-world data. Le-le Zhang is classified as an Experienced expert for Dendritic Cell Tumor, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Le-le Zhang participate in research or clinical trials?
Yes. Le-le Zhang has published 8 articles and abstracts on conditions like Dendritic Cell Tumor. You can view a list of Le-le Zhang's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Cerebral HypoxiaZhang isExperienced. Learn about Cerebral Hypoxia.
- Dendritic Cell TumorZhang isExperienced. Learn about Dendritic Cell Tumor.
- MononucleosisZhang isExperienced. Learn about Mononucleosis.
- Nasopharyngeal CarcinomaZhang isExperienced. Learn about Nasopharyngeal Carcinoma.